Come up with a name for your new list and we'll add to it:
Omthera Pharmaceuticals was acquired by
AstraZeneca on May 28, 2013.
Omthera Pharmaceuticals is a specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Omthera is dedicated to developing therapies for pati…